SphK-dependent regulation of FAK activity was also shown by Xu et al. [77] who reported that treatment of colorectal cancer cells with SphK1 inhibitor SKI-II abolished FAK activity to suppress EMT and colon cancer cell migration. This evidence concerns the gene PTK2 and malignant colon neoplasm.